Key facts
- Notable investors include Lazio Innova, Arieli Innovate.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Elysium
- ·The full record, as it builds
Funding rounds
No funding rounds for Elysium are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Elysium
Developer of a medical data sharing platform intended to facilitate global health information exchange and research. The company's platform, named Medory, allows individuals to securely share their medical history with doctors internationally, generating a large, anonymized dataset, enabling medical and pharmaceutical researchers to deliver safer and more efficient care by reducing diagnostic errors.
- Sector
- Healthcare
- HQ
- Rome, Italy
- Founded
- 2019
- Website
- elysium.tech/
- Ownership
- Privately Held (backing)
Elysium doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elysium shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elysium in its N-PORT filings yet. We sweep new filings monthly.